CIMERLI
- Product NDC
- 70114-440
- 11-digit product format
- 701140440
- Labeler code
- 70114
- Product ID
- 70114-440_4ce7246b-e546-412c-86c7-e23e3e215612
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ranibizumab-eqrn
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Labeler
- Coherus BioSciences Inc
- Application
- BLA761165
- Marketing category
- BLA
- Marketing start
- 2022-10-03
- Marketing end
- 2027-01-31
- Substance
- RANIBIZUMAB
- Active strength
- .3 mg/.05mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CIMERLI
Active Ingredients#
| Ingredient | Strength |
|---|---|
| RANIBIZUMAB | .3 mg/.05mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | ZL1R02VT79 |
| Rxcui | 2612675, 2612681, 2612684, 2612687 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 02a7bcab-2730-41aa-8529-7c6226e65bab | Product name | 1 | 20220516 |
| d6b571bf-7bed-4e31-93c1-5553936e1c45 | Product name | 1 | 20220315 |
| da4394b8-eff9-4932-92e2-14d8feb38640 | Product name | 1 | 20161208 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70114-440-01 | CIMERLI | 0.05 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 0.05 | 12 | |
| 70114-440-01 | CIMERLI | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 12 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70114-440-01 | ML - Milliliter | 70114-440 | 6f996b31-11fb-41aa-ad3d-591b27e61a2d | 1 | 2022-10-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2612681 | CIMERLI 0.3 MG in 0.05 ML Injection | PSN | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612687 | CIMERLI 0.5 MG in 0.05 ML Injection | PSN | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612675 | ranibizumab-eqrn 0.3 MG in 0.05 ML Injection | PSN | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612684 | ranibizumab-eqrn 0.5 MG in 0.05 ML Injection | PSN | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612687 | 0.05 ML ranibizumab-eqrn 10 MG/ML Injection [Cimerli] | SBD | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612681 | 0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli] | SBD | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612684 | 0.05 ML ranibizumab-eqrn 10 MG/ML Injection | SCD | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612675 | 0.05 ML ranibizumab-eqrn 6 MG/ML Injection | SCD | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612681 | Cimerli 0.3 MG per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612687 | Cimerli 0.5 MG per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612687 | Cimerli 10 MG/ML per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612681 | Cimerli 6 MG/ML per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612675 | ranibizumab-eqrn 0.3 MG per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612684 | ranibizumab-eqrn 0.5 MG per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612684 | ranibizumab-eqrn 10 MG/ML per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
| 2612675 | ranibizumab-eqrn 6 MG/ML per 0.05 ML Injection | SY | e0e23118-1490-a554-e053-2995a90ab90c | 12 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70114-440-01 | 70114044001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70114-440-01) / .05 mL in 1 VIAL, SINGLE-DOSE | 2022-10-03 | 2027-01-31 | No | No | Current |